People  |   Processes   |   Predictions

 LIVE ONLINE 7 October 2021

Advanced Therapies Integrates Speakers 2021

SHARON BROWNLOW

Chief Business Officer

Cell & Gene Therapy Catapult

TONY KHOURY

Executive Vice President

Project Farma

JANE THEAKER

Chief Executive Officer

Kinomica

JOE HEALY

Chief Executive Officer and
Co-Founder

NanoSyrinx

JAMES STRACHAN

 Editor

The Cell + Gene Curator

CHARLOTTE CASEBOURNE

Co-Founder & Chief Executive Officer

Theolytic

STEPHEN WARD

Chief Manufacturing Officer

Cell and Gene Therapy Catapult

BAKUL GUPTA

Chief Executive Officer and Co-founder

ImmTune Therapies

NICK STEPHENS

Executive Chairman

The RSA Group

ROUDIE SHAFIE

Director

OVID Health

CHRIS NOWERS

Chief Executive Officer

ONK Therapeutics

NATHAN SIGWORTH

Co-founder and Chief Executive Officer

PharmaCCX

NAZNEEN RAHMAN CBE

Non-Executive Director

AstraZeneca

SVEN KILI

Chief Executive Officer

Antion Biosciences

CAROLE LONGSON

Independent Senior Adviser

Life Science Policy, HTA and Market Access

DAVID BLAKEY

Senior Vice President Strategic Alliances

MiNA Therapeutics

FIONA THISTLETHWAITE

Medical Oncology Consultant

The Christie NHS Foundation Trust

JASON MELLAD

Chief Executive Officer

Start Codon

BRIAN HARRISON

Managing Director

HiTech Health

SARAH BRUCE-WHITE

Partnerships & Programme’s Lead

MedCity

BRUCE LEVINE

Founding Director

Clinical Cell and Vaccine Production Facility

STEVE McCONCHIE

Chief Executive Officer

Aptus Clinical

JAMES KUSENA

Head of Bioprocessing

MicrofluidX

TAMAS MASZTIS

Senior Director, Cell Therapy Supply Chain for Europe

Kite, a Gilead Company

SIMON PEGG

Director

Project-Ion

FABIO D’AGOSTINO

Venture Partner

Claris Ventures SGR

ALASTAIR THONG

Founder

Selvedge Venture

MALCOLM BARRATT-JOHNSON

Managing Director

PharmaMedic Consultancy Ltd

JASON C. FOSTER

Chief Executive Officer and Executive Director

Ori Biotech

STEPHEN LITTLE

Vice Chairman

Yourgene Health

ERIC HALIOUA

President & Chief Executive Officer

PDC*line Pharma

SALLY ANN FORSYTH OBE

Chief Executive Officer

Stevenage Bioscience Catalyst

FERNANDA MASRI

Head of Commercial for the Manufacturing Centre

Cell and Gene Therapy Catapult

TERRI GASKELL

Chief Technical Officer

Rinri Therapeutics Ltd.

JENNY LAIRD

Vice President, Search & Evaluation Pain & Neurodegeneration

Eli Lilly and Company

KASIA AVERALL

Head of Cluster Development

Cell and Gene Therapy Catapult

JAMES FRY

Partner and Head of Life Sciences

Mills & Reeve

LEE CONEY

Head of Non-Clinical Safety

Cell and Gene Therapy Catapult

COLIN MACKAY

Founder and Chief Executive Officer

Symbiosis Pharmaceutical Services

MARTINO PICARDO

Chairman

Discovery Park

JESÚS ZURDO

Global Head Cell, Gene Therapy & Bioproduction

Horizon Discovery

ANTHONY WILSON

Consultant in Anaesthesia and Critical Care

Manchester University NHS Foundation Trust

LUCY FOLEY

Director of Biologics

CPI

ROBERT JONES

Vice President, Global BioServices

Cryoport Systems

TIM LUKER

Vice President Emerging Technology and Innovation

Eli Lilly

TIMOTHY NEWTON

Founder and Chief Executive Officer

Reflection Therapeutics

BILL SHINGLETON

Director, Applications and Biology: Cell and Gene Therapy

Cytiva

KEITH FOSTER

Chief Scientific Officer

Sutura Therapeutics

JAMES GREGORY

Managing Partner

The RSA Group

EMILY MERRELL

Interim Head of ATTC Network Coordination

Cell and Gene Therapy Catapult

JANE KENNEDY

Chief Business Officer

Discovery Park

CLAIRE THOMPSON

Chief Executive Officer

Agility Life Sciences

MARK FOWLER

Global Head of Procurement & Sourcing

Autolus Therapeutics

MARY JONES

Deputy Director for Strategy, Investment and Manufacturing

Office for Life Sciences

BILL SCOTT

Scientific Director, Transplant Regenerative Medicine

Newcastle University Medical School

KATE COLEMAN

Senior Director and Principal Consultant

PharmaLex

AHMED BOUZIDI

Vice-President Biotech

ProductLife Group

DAN PEARCE

Vice President, European Manufacturing & Technical Operations

Adaptimmune

WILL ROHLEDER

Development Director

Reef

CLARE HAGUE

Therapy Area Market Access Lead, Hematology (EMEA)

Janssen

KEVIN BRUCE

Chief Operating Officer

Roslin Cell Therapies Ltd

AGATHE GUILLOT

Head of Regulatory Affairs

Cell and Gene Therapy Catapult

STEVEN TAIT

Senior business manager

LifeArc

GAVIN LEWIS

Vice President, Global Value and Access

Amgen (Europe) GmbH

People  |   Processes   |   Predictions

 LIVE ONLINE 7 October 2021